We are live on
!
Find out more
SO
STRS Ohio Portfolio holdings
AUM
$25.2B
1-Year Est. Return
30.31%
This Fund
S&P 500
This Quarter
Est. Return
+2.48%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$22.7B
AUM Growth
-$392M
(-1.7%)
Cap. Flow
-$683M
Cap. Flow
% of AUM
-3.01%
Top 10 Holdings %
Top 10 Hldgs %
13.52%
Holding
1,954
New
218
Increased
445
Reduced
978
Closed
152
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Weyerhaeuser
WY
|
+$41.7M |
| 3 |
Mondelez International
MDLZ
|
+$34M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$33.6M |
| 5 |
Lazard
LAZ
|
+$28.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$96.8M |
| 2 |
HCA Healthcare
HCA
|
+$70.3M |
| 3 |
HP
HPQ
|
+$51.1M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$49.2M |
| 5 |
T. Rowe Price
TROW
|
+$47.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.91% |
| 2 | Technology | 14.75% |
| 3 | Healthcare | 14.19% |
| 4 | Industrials | 9.98% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CJES
1501
DELISTED
C&J ENERGY SVCS LTD
CJES
| $173K | ﹤0.01% |
15,600
+4,700
| +43% | +$56.1K |
|
1502
Coca-Cola Europacific Partners
CCEP
$46.5B
| $172K | ﹤0.01% |
+3,905
| New | +$171K |
|
1503
Darling Ingredients
DAR
$9.93B
| $172K | ﹤0.01% |
12,300
-232,700
| -95% | -$3.83M |
|
1504
Rush Enterprises Class A
RUSHA
$5.95B
| $171K | ﹤0.01% |
14,144
-36,706
| -72% | -$464K |
|
|
LLTC
1505
DELISTED
Linear Technology Corp
LLTC
| $171K | ﹤0.01% |
+3,668
| New | +$172K |
|
|
ARG
1506
DELISTED
Airgas Inc
ARG
| $171K | ﹤0.01% |
1,612
-59,388
| -97% | -$6.74M |
|
|
KEG
1507
DELISTED
KEY ENERGY SERVICES INC
KEG
| $171K | ﹤0.01% |
94,200
-2,400
| -2% | -$4.36K |
|
1508
Healthcare Services Group
HCSG
$1.56B
| $170K | ﹤0.01% |
5,300
-200
| -4% | -$6.46K |
|
1509
DaVita
DVA
$15.1B
| $169K | ﹤0.01% |
2,082
-14,094
| -87% | -$1.08M |
|
1510
Synopsys
SNPS
$71.5B
| $169K | ﹤0.01% |
3,670
-3,148
| -46% | -$141K |
|
1511
Expedia Group
EXPE
$31.2B
| $168K | ﹤0.01% |
+1,794
| New | +$159K |
|
1512
Lifetime Brands
LCUT
$199M
| $168K | ﹤0.01% |
11,000
-5,100
| -32% | -$80K |
|
1513
J.M. Smucker
SJM
$12.6B
| $168K | ﹤0.01% |
1,460
-1,490
| -51% | -$163K |
|
|
KITE
1514
DELISTED
Kite Pharma, Inc.
KITE
| $167K | ﹤0.01% |
2,900
-100
| -3% | -$6.7K |
|
|
CVG
1515
DELISTED
Convergys
CVG
| $166K | ﹤0.01% |
7,300
+1,300
| +22% | +$27.5K |
|
1516
Corpay
CPAY
$24.2B
| $165K | ﹤0.01% |
1,098
-78,902
| -99% | -$11.7M |
|
|
GEVA
1517
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $165K | ﹤0.01% |
1,700
+1,000
| +143% | +$106K |
|
|
SHOE
1518
Shoe Station Group
SHOE
$395M
| $164K | ﹤0.01% |
+11,200
| New | +$139K |
|
|
POLY
1519
DELISTED
Plantronics, Inc.
POLY
| $164K | ﹤0.01% |
3,100
-10,200
| -77% | -$522K |
|
1520
Omega Flex
OFLX
$298M
| $163K | ﹤0.01% |
6,500
-200
| -3% | -$6.19K |
|
|
HTO
1521
H2O America
HTO
$2.67B
| $163K | ﹤0.01% |
+5,300
| New | +$174K |
|
1522
Alkermes
ALKS
$8.82B
| $162K | ﹤0.01% |
+2,672
| New | +$183K |
|
1523
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.9B
| $162K | ﹤0.01% |
8,900
-200
| -2% | -$3.18K |
|
1524
Expeditors International
EXPD
$22.9B
| $160K | ﹤0.01% |
3,340
-657
| -16% | -$30.2K |
|
1525
Mercantile Bank Corp
MBWM
$1.01B
| $160K | ﹤0.01% |
8,187
-6,513
| -44% | -$126K |
|
Similar funds
KK
VAI
UIM
STRS Ohio's Q1 2015 Portfolio in Review
As of Q1 2015, STRS Ohio held 1,954 positions worth $22.7B, down 1.7% from $23.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
STRS Ohio withdrew a net $683M in Q1 2015, closing 152 positions and reducing 978 holdings. Its most notable exit was Allergan Inc, an estimated $96.8M position sold in full.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 16% a quarter earlier, followed by Technology and Healthcare.
Against the trend, STRS Ohio opened a new position in Lazard worth $30.5M.
- STRS Ohio's largest Q1 2015 buy was Lazard: 580,430 shares worth $30.5M.
- STRS Ohio added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- STRS Ohio's biggest Q1 2015 reduction was HCA Healthcare, cutting an estimated $70.3M.
- STRS Ohio fully exited Allergan Inc in Q1 2015, selling an estimated $96.8M.
- STRS Ohio's ten largest holdings make up 14% of its $22.7B portfolio in Q1 2015.
- STRS Ohio opened 218 new positions and closed 152 in Q1 2015.
- STRS Ohio's portfolio value fell 1.7% quarter-over-quarter to $22.7B.
Based on STRS Ohio's 13F filing for Q1 2015, filed 21 Apr 2015.